文章引用说明 更多>> (返回到该文章)

Matar, A.A. and Chong, J.J. (2014) Stem Cell Therapy for Cardiac Dysfunction. Springerplus, 3, 440.
http://dx.doi.org/10.1186/2193-1801-3-440

被以下文章引用:

  • 标题: 干细胞生物技术专利信息情报初步分析Preliminary Information Analysis of the Stem Cell Biotechnology Patents

    作者: 姜铁竹, 刘书朋, 李苗, 张永娟, 陈成材, 孙瑞阳, 陈恒

    关键字: 干细胞, 生物技术专利, 信息统计, 情报分析Stem Cell, Biotechnological Patent, Information Statistics, Information Analysis

    期刊名称: 《QianRen Biology》, Vol.2 No.4, 2015-12-30

    摘要: 本文主要对国内外干细胞生物技术相关专利进行了有效的检索、收集与分类整理,并进一步对国内外干细胞生物技术相关专利信息进行了统计和深入的情报分析。统计显示,中国在干细胞生物技术专利领域的国际专利申请为830件,而国际专利4260件,国际专利中主要为美国、日本和韩国等国家的专利申请,说明美国、日本和韩国等在干细胞生物技术领域的研究已走在了我国前头,因此,我国必须继续加强干细胞生物技术的研究和相关专利的申请,同时也急需促进干细胞生物技术产业领域的发展。 This paper focused on the effective search, collection and classification of domestic and interna-tional stem cell biotechnology patents. Furthermore, deep analysis and statistics of the stem cell biotechnology patents were performed. The results show that the stem cell biotechnology patents in China were about 830 items and the international stem cell biotechnology patents were about 4260 items. American, Japan and South Korea, as several countries with the most number of patents applications, have gone ahead of China in stem cell biotechnology research field. Therefore, China must continue to reinforce the stem cell biotechnology researches and the related patents applications, and also urgently to promote the industrial development of the stem cell biotechnology field simultaneously.

在线客服:
对外合作:
联系方式:400-6379-560
投诉建议:feedback@hanspub.org
客服号

人工客服,优惠资讯,稿件咨询
公众号

科技前沿与学术知识分享